낭포성 섬유증용 기도 확보 장치 시장 : 시장 인사이트, 경쟁 구도 및 시장 예측(-2032년)
Airway Clearance Devices for Cystic Fibrosis - Market Insights, Competitive Landscape, and Market Forecast - 2032
상품코드:1656910
리서치사:DelveInsight
발행일:On Demand Report
페이지 정보:영문 150 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
낭포성 섬유증용 기도 확보 장치 시장 규모는 예측 기간 동안 5.03%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.
낭포성 섬유증용 기도 확보 장치 수요는 낭포성 섬유증 유병률 증가, 유전성 질환 사례 증가, 연구개발 활동 증가, 주요 기업 간 연구 협력 등에 의해 촉진되고 있습니다.
낭포성 섬유증용 기도 확보 장치 시장 역학:
2023년 1월 영국 의회가 발표한 보고서에 따르면 2023년 영국에서 약 1,800명이 낭포성 섬유증을 앓고 있으며, 2024년 5월 Vertex Pharmaceuticals Incorporated의 발표에 따르면 전 세계적으로 9만 2,000명이 낭포성 섬유증 진단을 받은 것으로 추정됩니다. 낭포성 섬유증 진단을 받은 것으로 추정되고 있습니다. 기도 확보 장치는 기도 벽을 깨끗하게 하여 낭포성 섬유증 관리에 도움이 되기 때문에 낭포성 섬유증 유병률 증가는 시장 성장을 가속할 것으로 예상됩니다.
시장의 주요 기업들은 병원 및 재택치료용 기도 확보 장치의 개발 및 상용화에 주력하고 있습니다. 주요 기업들의 연구개발 활동이 활발해지면서 낭포성 섬유증용 기도확보장치 시장의 성장을 견인하고 있습니다.
장치 유형별로는 고주파 흉벽 진동 장치 부문이 2024년 가장 큰 매출 점유율을 차지할 것으로 추정됩니다. 고주파 흉벽 진동 장치는 흉벽의 기계적 진동 또는 진동을 이용하여 기도에 축적된 점액의 배출을 돕고 점액의 이완과 동원을 촉진합니다. 이 장치는 기도 벽에서 가래와 점액을 제거해야 하는 만성 폐 질환의 치료에도 사용됩니다.
지역별로는 북미가 2024년 압도적인 시장 점유율을 보일 것으로 예상됩니다. 이는 이 지역에서 낭포성 섬유증의 유병률이 증가하고 있기 때문입니다.
세계의 낭포성 섬유증용 기도 확보 장치 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법 및 규제 환경, 시장 규모 추이 및 예측, 각종 부문별/지역별/주요 국가별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 낭포성 섬유증용 기도 확보 장치 시장 보고서 : 서론
조사 범위
시장 세분화
시장 전제 요인
제2장 낭포성 섬유증용 기도 확보 장치 시장 : 주요 요약
시장 개요
제3장 경쟁 구도
제4장 규제 분석
미국
유럽
일본
중국
제5장 낭포성 섬유증용 기도 확보 장치 시장 : 주요 요인 분석
시장 성장 촉진요인
시장 성장 억제요인과 과제
시장 기회
제6장 낭포성 섬유증용 기도 확보 장치 시장 : Porter의 Five Forces 분석
제7장 낭포성 섬유증용 기도 확보 장치 시장 평가
디바이스 유형별
고주파 흉벽 진동 디바이스
호기양압 디바이스
메커니컬 퍼크션(MP) 디바이스
기타
최종사용자별
병원 및 진료소
재택치료
지역별
북미
유럽
아시아태평양
기타 지역
제8장 낭포성 섬유증용 기도 확보 장치 시장 : 기업 및 제품 개요
Baxter
Koninklijke Philips N.V.
Electromed, Inc.
ICU Medical, Inc.
Trudell Medical International
CEGLA Medizintechnik GmbH
PARI GmbH
Monaghan
VORTRAN Medical Technology 1 Inc.
Tactile Medical
Mercury Medical
Med Systems, Inc.
Vyaire Medical, Inc.
Synchrony Medical
Dymedso
SunMed LLCWestmed, Inc.
RespInnovation
Inogen, Inc.
Thayer Medical
Medline Industries, LP
제9장 KOL(Key Opinion Leader)의 견해
제10장 프로젝트 접근
제11장 DelveInsight에 대해
제12장 면책사항 및 문의
LSH
영문 목차
영문목차
Airway Clearance Devices for Cystic Fibrosis Market by Device Type (High-Frequency Chest Wall Oscillation Device, Positive Expiratory Pressure Devices, Mechanical Percussion (MP) Devices, and Others), End-User (Hospitals & Clinics, Home Healthcare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the growing prevalence of cystic fibrosis and respiratory disorders and rising incidence of genetic diseases
The airway clearance devices for cystic fibrosis market is estimated to grow at a CAGR of 5.03% during the forecast period from 2025 to 2032. The demand for airway clearance devices for cystic fibrosis is primarily driven by the growing prevalence of cystic fibrosis, increasing genetic disease cases, growing R&D activities, and research collaboration among key players are some of the key factors responsible for contributing to the positive growth of airway clearance devices for the cystic fibrosis market during the forecast period from 2025 to 2032.
Airway Clearance Devices for Cystic Fibrosis Market Dynamics:
The airway clearance devices are created based on physiological principles that work by creating resistance and vibration that help to loosen and clear mucous from airway walls to enhance sputum clearance. According to a report published by the UK Parliament in January 2023, stated that approximately 10,800 people were living with cystic fibrosis in 2023 in the United Kingdom. According to Vertex Pharmaceuticals Incorporated in May 2024, it was estimated that 92,000 people were diagnosed with cystic fibrosis across the globe. Airway clearance devices help to manage cystic fibrosis by clearing the airway walls, thus, the rising prevalence of cystic fibrosis is expected to drive the market growth.
Cystic fibrosis is a genetic condition caused by gene abnormality that causes the production of abnormally thick and sticky liquid called mucous. According to NHS England in February 2024, approximately 3.5 million people were affected by genetic diseases in 2021 in the United Kingdom and this number comprises 1 in 17 people being affected by a rare disease. Therefore, the rising occurrence of rare genetic diseases contributes to increased cases of cystic fibrosis which is contributing to the growth of the market.
Key players in the market are concentrating their efforts on developing and commercializing airway clearance devices for hospital and home healthcare applications. For instance, in December 2022, ABM Respiratory Care announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the BiWaze(R) Clear System. This airway clearance system helps patients clear their airways as well as prevent or treat cystic fibrosis by using oscillating lung expansion (OLE) therapy. Therefore, the increasing research and development activities by key players are driving the growth of airway clearance devices for the cystic fibrosis market.
However, the complications associated with airway clearance devices, and product recalls, among others are some of the key constraints that may hinder the growth of airway clearance devices for the cystic fibrosis market.
Airway Clearance Devices for Cystic Fibrosis Market Segment Analysis:
Airway Clearance Devices for Cystic Fibrosis Market by Device Type (High-Frequency Chest Wall Oscillation Device, Positive Expiratory Pressure Devices, Mechanical Percussion (MP) Devices, and Others), End-User (Hospitals & Clinics, Home Healthcare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the device type segment of airway clearance devices for the cystic fibrosis market, the high-frequency chest wall oscillation device category is estimated to hold the largest revenue share in the airway clearance devices for the cystic fibrosis market in 2024. High-frequency chest wall oscillation devices use mechanical oscillations or vibrations on the chest wall to aid in the clearance of accumulated mucus from the airways, facilitating its loosening and mobilization. This device is also used for the treatment of chronic lung diseases which require clearance of sputum and mucous from airway walls.
Key players in the market are developing advanced devices for the management of cystic fibrosis and other disease that require devices for airway clearances. For instance, in November 2022, Electromed, Inc. announced that it received U.S Food and Drug Administration 510(k) clearance for the SmartVest(R) Clearway(R) Airway Clearance System, which is designed for High-Frequency Chest Wall Oscillation therapy. This device works by delivering alternating pulses of air into a vest, causing rapid compression and release of the chest wall. This process generates airflow oscillations within the airways, which serve to loosen, thin, and propel mucus towards the larger airways for easier expectoration.
Therefore, the growing use of high-frequency chest wall oscillation devices in cystic fibrosis is expected to contribute to the growth of the segment, thereby driving the growth of the airway clearance devices for the cystic fibrosis market during the forecast period.
North America is expected to dominate the overall Airway Clearance Devices for Cystic Fibrosis Market:
North America is expected to hold dominate market share in the airway clearance devices for cystic fibrosis market in 2024. This is due to the growing prevalence of cystic fibrosis in the region. The rising number of people suffering from cystic fibrosis requiring airway clearance devices to manage disease conditions in the region is a key factor driving the growth of the North America airway clearance devices for cystic fibrosis market.
Air clearance devices mechanically conducts chest physical therapy through high-frequency vibrations. The vest vibrates the chest to help loosen and thin thick, sticky mucus commonly found in cystic fibrosis. According to data published by Centers for Disease Control and Prevention (CDC) in May 2024, approximately 35,000 peoples were suffering with cystic fibrosis in 2024 in the United States. Therefore, the rising cases of cystic fibrosis is expected to drive the market growth in North America.
Airway Clearance Devices for Cystic Fibrosis Market Key Players:
Some of the key market players operating in the airway clearance devices for cystic fibrosis market include Baxter, Koninklijke Philips N.V., Electromed, Inc., ICU Medical, Inc., Trudell Medical International, CEGLA Medizintechnik GmbH, PARI GmbH, Monaghan, VORTRAN Medical Technology 1 Inc., Tactile Medical, Mercury Medical, Med Systems, Inc., Vyaire Medical, Inc., Synchrony Medical, Dymedso, SunMed LLCWestmed, Inc., RespInnovation, Inogen, Inc., Thayer Medical, Medline Industries, LP, and others.
Recent Developmental Activities in the Airway Clearance Devices for Cystic Fibrosis Market:
In September 2023, Inogen, Inc. completed the acquisition of Physio-Assist SAS. Through this acquisition, Inogen acquired Simeox from Physio-Assist which is a technology-enabled airway clearance and mucus management device for treatment of cystic fibrosis.
In September 2021, Tactile Medical completed acquisition of AffloVest respiratory therapy business from International Biophysics Corporation. This acquisition strengthened the position of Tactile Medical in cystic fibrosis treatment market and increased its product portfolio and global presence.
Key Takeaways from the Airway Clearance Devices for Cystic Fibrosis Market Report Study
Market size analysis for current Airway Clearance Devices For Cystic Fibrosis Market size (2024), and market forecast for 8 years (2025 to 2032)
Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the global Airway Clearance Devices for Cystic Fibrosis market.
Various opportunities available for the other competitors in the Airway Clearance Devices for Cystic Fibrosis Market space.
What are the top-performing segments in 2024? How these segments will perform in 2032?
Which are the top-performing regions and countries in the current Airway Clearance Devices for Cystic Fibrosis market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Airway Clearance Devices for Cystic Fibrosis market growth in the coming future?
Target Audience who can be benefited from this Airway Clearance Devices for Cystic Fibrosis Market Report Study
Airway Clearance Devices For Cystic Fibrosis product providers
Research organizations and consulting companies
Airway Clearance Devices For Cystic Fibrosis related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in Airway Clearance Devices For Cystic Fibrosis
Various end-users who want to know more about the Airway Clearance Devices for Cystic Fibrosis Market and the latest technological developments in the Airway Clearance Devices for Cystic Fibrosis Market.
Frequently Asked Questions for the Airway Clearance Devices for Cystic Fibrosis Market:
1. What are Airway Clearance Devices for Cystic Fibrosis?
Airway clearance devices for cystic fibrosis are specialized devices that mechanically aid in clearing thick, sticky mucus from the airways, thereby enhancing lung function and improving airways wall clearance.
2. What is the market for Airway Clearance Devices for Cystic Fibrosis?
The airway clearance devices for cystic fibrosis market is estimated to grow at a CAGR of 5.03% during the forecast period from 2025 to 2032.
3. What are the drivers for the global Airway Clearance Devices for Cystic Fibrosis market?
The airway clearance devices for cystic fibrosis market is slated to witness prosperity owing to factors such as the growing prevalence of cystic fibrosis, increasing genetic disease cases, growing R&D activities, research collaborations among key players are some of the key factors responsible for contributing to the positive growth of the airway clearance devices for cystic fibrosis market during the forecast period from 2025 to 2032.
4. Who are the key players operating in the global Airway Clearance Devices for Cystic Fibrosis market?
Some of the key market players operating in the airway clearance devices for cystic fibrosis market include Baxter, Koninklijke Philips N.V., Electromed, Inc., ICU Medical, Inc., Trudell Medical International, CEGLA Medizintechnik GmbH, PARI GmbH, Monaghan, VORTRAN Medical Technology 1 Inc., Tactile Medical, Mercury Medical, Med Systems, Inc., Vyaire Medical, Inc., Synchrony Medical, Dymedso, SunMed LLCWestmed, Inc., RespInnovation, Inogen, Inc., Thayer Medical, Medline Industries, LP, and others.
5. Which region has the highest share in the global Airway Clearance Devices For Cystic Fibrosis market?
North America is expected to hold dominate market share in the airway clearance devices for cystic fibrosis market in 2024. This is due to the growing prevalence of cystic fibrosis in the region. Thus the rising number of people suffering from cystic fibrosis requiring airway clearance devices to manage disease conditions in the region is a key factor driving the growth of the North America airway clearance devices for cystic fibrosis market.
Table of Contents
1. Airway Clearance Devices For Cystic Fibrosis Market Report Introduction
1.1. Scope of the Study
1.2. Market Segmentation
1.3. Market Assumption
2. Airway Clearance Devices For Cystic Fibrosis Market Executive Summary
